ELMWOOD PARK, N.J., July 22, 2013 /PRNewswire/ -- Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) ( www.bioreference.com) announced today that it signed a licensing agreement with the University of Washington to transition GeneTests.org, GeneClinics.org and all other related properties to become a business unit of Bio-Reference.
Since 1992, GeneTests.org has been a key resource for physicians, geneticists and genetic counselors seeking comprehensive information about testing for inherited disorders and genetic counseling services. In fact, GeneTests.org receives about 22,000 visitors each business day.
"GeneTests.org is highly regarded by everyone in the field," said vice president of marketing for Bio-Reference, Amar Kamath. "We recognized that GeneTests.org has been providing a community service since molecular genetics was in its infancy, and we're pleased to be preserving and maintaining this valuable resource free-of-charge to users. It would have been a huge loss to the medical community to let it go."
GeneTests.org lists more than 600 international labs offering genetic testing for more than 3,000 disorders. In addition, GeneTests.org provides information concerning over 1,100 international genetics clinics, which provide diagnostic and genetic counseling services to patients and their families.Both directories are provided free of charge to the public and participating laboratories and clinics. "As the field of genetics has grown more complex and specialized, GeneTests.org has become one of the most indispensable tools of the trade as a single source of information on genetic test availability," said GeneTests.org founder Roberta "Bonnie" Pagon, M.D., who is now a consultant to Bio-Reference and has assumed the role of Medical Director of GeneTests.org. "Initially, the lab directory was used primarily by geneticists, but today clinicians in all specialties, such as cardiology, endocrinology and neurology, rely on GeneTests.org for easy-to-access, easy-to-understand information on tests for inherited disorders."
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV